An observational study in Periodontitis, Gingivitis and Periodontal Disease, sponsored by Abant Izzet Baysal University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by Abant Izzet Baysal University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Periodontitis by Abant Izzet Baysal University — 2 open to participants now, 2 under way, none of them phase 3. Periodontitis · Abant Izzet Baysal University.
Among the 11 studies in Periodontitis by Abant Izzet Baysal University, this one is one of 3 that started in 2026, is one of 7 observational ones, and was the 10th registered.
1,235 studies on the registry are indexed under Periodontitis; 298 are open to participants now.
Browse Periodontitis studies →2 of the 11 studies in Periodontitis by Abant Izzet Baysal University are open now, in 1 country. Recruiting first, the newest first:
Abant Izzet Baysal University · Sites in Turkey
Ages 18–65 · Healthy volunteers
Abant Izzet Baysal University · Sites in Turkey
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 160 Periodontitis studies recruiting now, 79 (49%) set no upper age limit and 60 (38%) stop at 75 or younger; 12 take children under 18; 77 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 3 started in 2026.
This study's enrollment of 81 is close to the median of 90 across 374 observational studies indexed under Periodontitis.
Median enrollment 66 across the 4 interventional studies, 120 across the 7 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Abant Izzet Baysal University is the lead sponsor of 250 studies on the registry; 59 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 11 studies in Periodontitis by Abant Izzet Baysal University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This observational study aims to evaluate the levels of specific biological markers-Parathyroid Hormone-Related Protein (PTHrP), RANKL, and Osteoprotegerin (OPG)-in the gingival crevicular fluid of individuals with different gum health conditions. The study includes a total of 81 participants, divided equally into three groups: 27 with healthy gums, 27 with gingivitis, and 27 with periodontitis. During a routine dental visit, participants undergo a standard periodontal examination to measure clinical signs such as plaque levels, gum bleeding, and pocket depths. Additionally, small sterile paper strips are gently placed in the gum crevices for 30 seconds to collect fluid samples. These fluid samples are then analyzed in a laboratory to understand how these specific proteins relate to gum health and the severity of gum disease.
Periodontitis is a chronic inflammatory disease characterized by the destruction of tooth-supporting tissues and alveolar bone loss, primarily driven by an imbalance in bone metabolism. The regulation of bone turnover relies heavily on the balance between RANKL, which promotes osteoclast activation, and OPG, its natural inhibitor. Furthermore, PTHrP acts as a critical autocrine and paracrine regulator in periodontal tissue health and alveolar bone repair. The primary rationale of this research is to investigate the dynamic role of PTHrP in periodontal pathogenesis during both the inflammatory and tissue-destruction phases, evaluating its potential as a biological marker. Following a comprehensive clinical periodontal examination by a single calibrated clinician, specific sampling sites are isolated with cotton rolls and gently air-dried. Supragingival plaque is carefully removed prior to sampling. Gingival crevicular fluid (GCF) is then collected from these designated interproximal sites using sterile filter paper strips, which are inserted into the sulcus until mild resistance is felt and left in place for 30 seconds. Samples contaminated with blood or saliva are immediately excluded. The exact volume of the collected fluid is quantified using an electronic volume meter (Periotron 8010). All valid strips are subsequently transferred to microcentrifuge tubes and preserved at -80°C until laboratory processing. The biochemical quantification of PTHrP, RANKL, and OPG levels is performed via commercially available Enzyme-Linked Immunosorbent Assay (ELISA) kits in accordance with the manufacturer's protocols.
The study population consists of adult individuals seeking dental care at the Department of Periodontology, Faculty of Dentistry, Bolu Abant Izzet Baysal University. The population includes a total of 81 participants representing three distinct periodontal conditions: individuals with a healthy periodontium, individuals diagnosed with gingivitis, and individuals diagnosed with Stage III periodontitis.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.
Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hepatitis B tests
Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.
Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
27 individuals with probing depth (PD) ≤ 3 mm, bleeding on probing (BOP) \< 10%, and no interproximal clinical attachment loss (CAL) or radiographic bone loss (RBL).
Other: Routine periodontal clinical examination and GCF collection
27 individuals with PD ≤ 3 mm, BOP ≥ 30%, and no CAL or RBL.
Other: Routine periodontal clinical examination and GCF collection
27 individuals diagnosed with Stage III periodontitis, characterized by interproximal CAL ≥ 5 mm, PD ≥ 6 mm, and RBL extending to the middle third of the root or more apically.
Other: Routine periodontal clinical examination and GCF collection
A comprehensive clinical periodontal examination is performed by a single calibrated examiner using a periodontal probe. The examination includes the measurement of Plaque Index (PI), Gingival Index (GI), PD, and CAL. For GCF collection, the specified interproximal sites are isolated with cotton rolls, gently air-dried, and cleared of supragingival plaque. GCF samples are then collected using sterile filter paper strips inserted into the sulcus until mild resistance is felt and left in place for 30 seconds.
GCF Level of PTHrP
The concentration of PTHrP in GCF samples will be quantitatively measured using commercial ELISA kits.
Time frame: Baseline (Single time point during the clinical examination)
GCF Level of RANKL
The concentration of RANKL in GCF samples will be quantitatively measured using commercial ELISA kits.
Time frame: Baseline (Single time point during the clinical examination)
GCF Level of Osteoprotegerin
The concentration of OPG in GCF samples will be quantitatively measured using commercial ELISA kits.
Time frame: Baseline (Single time point during the clinical examination)
Probing Depth (PD)
PD will be measured using a periodontal probe at six sites per tooth (mesiobuccal, midbuccal, distobuccal, mesiopalatal/lingual, midpalatal/lingual, and distopalatal/lingual). Measurements will be rounded to the nearest millimeter.
Time frame: Baseline (Single time point during the clinical examination)
Clinical Attachment Level (CAL)
CAL will be calculated by measuring the distance from the cementoenamel junction to the base of the probable pocket using a periodontal probe.
Time frame: Baseline (Single time point during the clinical examination)
Gingival Index (GI)
GI will be evaluated according to the method described by Löe and Silness. Four surfaces of each tooth (buccal, lingual/palatal, mesial, and distal) will be scored to calculate the full-mouth average GI score.
Time frame: Baseline (Single time point during the clinical examination)
Plaque Index (PI)
PI will be evaluated according to the method described by Löe and Silness. Four surfaces of each tooth will be scored to calculate the full-mouth average PI score.
Time frame: Baseline (Single time point during the clinical examination)
Plan to share: No
No publications or documents are linked to this record.
Ran from Jun 2026 to primary completion in Jul 2026, 1 month.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Abant Izzet Baysal University →